Bracci, Paige M.
Rice, Terri
Hansen, Helen M.
Francis, Stephen S.
Lee, Sean
McCoy, Lucie S.
Shrestha, Pavan P.
Warrier, Gayathri
Clarke, Jennifer L.
Molinaro, Annette M.
Taylor, Jennie W.
Wiencke, John K.
Wrensch, Margaret R.
Funding for this research was provided by:
National Institutes of Health (P50CA097257, P50CA097257, P50CA097257, R01CA207360, P50CA097257, P50CA097257, R01CA207360, P50CA097257, P50CA097257, P50CA097257, P50CA097257, P50CA097257)
Article History
Received: 18 April 2022
Accepted: 24 May 2022
First Online: 18 June 2022
Declarations
:
: JKW is a cofounder of Cellintec, which played no role in the current study. He has no financial disclosure or conflict of interest related to the material and research in this paper.
: This research was presented as an on-demand pre-recorded oral presentation at the Society for Neuro-Oncology (SNO) Annual Meeting (November 19–22, 2020) and the Brain Tumor Epidemiology Consortium Annual Meeting (June 22–25, 2021).